Aptevo Therapeutics

Filed a patent for "bispecific pd-l1 and cd40 binding molecules and uses thereof" on Fri, January 6, 2023

Filed a patent for "cd123 binding proteins and related compositions and methods" on Thu, October 17, 2024

Filed a patent for "compositions comprising 4-1bb and ox40 binding proteins and methods of use" on Thu, May 9, 2024

Filed a patent for "dosing regimens for protein therapeutics" on Mon, November 20, 2023

Filed a patent for "methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components" on Thu, May 18, 2023

Filed a patent for "formulations for protein therapeutics" on Thu, September 28, 2023